Robert Clark
Director/Board Member at INCANNEX HEALTHCARE INC.
Net worth: 283 000 $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert Bourla | M | 62 | 31 years | |
| Joseph Swan | M | 33 | - | |
| Joel Latham | M | 35 | 6 years | |
| Lars Green | M | 57 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 10 years |
| Sue Desmond-Hellmann | M | 66 | 4 years | |
| Douglas Lankler | M | 58 | 25 years | |
| Sally Susman | F | 62 | 17 years | |
| Troy Valentine | M | 51 | 7 years | |
| Rady Johnson | M | 63 | 30 years | |
| Shantanu Narayen | M | 60 | 11 years | |
| Dan Littman | M | 71 | 6 years | |
| Joseph Echevarria | M | 66 | 9 years | |
| Ronald Blaylock | M | 64 | 7 years | |
| James Quincey | M | 59 | 4 years | |
| Helen Hobbs | M | 71 | 13 years | |
| Jim Smith | M | 64 | 10 years | |
| Peter Widdows | M | 58 | 6 years | |
| Scott Gottlieb | M | 51 | 5 years | |
| Suzanne Johnson | F | 66 | 17 years | |
| Kenneth Inchausti | M | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | - |
| Susan Hockfield | M | 73 | 4 years | |
| Mark Bleackley | M | - | 4 years | |
| Payal Sahni Becher | F | - | 27 years | |
| Steve Danehy | M | - | 12 years | |
| Mike McDermott | M | 58 | 21 years | |
| Barbara Dalton | M | 69 | 17 years | |
| Markus Green | M | - | 18 years | |
| Rosemarie Walsh | F | - | 4 years | |
| Angelo Carter | M | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | - |
| Jeff Settleman | M | - | 5 years | |
| Gordon Loh | M | - | 4 years | |
| Annaliesa Anderson | M | - | 17 years | |
| Aaron Foster | M | - | 5 years | |
| Parisa Asvadi | M | - | - | |
| Aida Habtezion | M | - | 3 years | |
| Joel Schrock | M | - | 4 years | |
| Denis Patrick | M | - | 14 years | |
| Brad Dilkes | M | - | - | |
| Bryan Supran | M | - | 8 years | |
| Doug Langa | M | 58 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 13 years |
| Suneet Varma | M | 55 | 23 years | |
| François-Maurice Garnier | M | 62 | 21 years | |
| Jennifer Damico | F | 56 | 4 years | |
| Lekhram Changoer | M | 56 | 2 years | |
| George Anastassov | M | 60 | 2 years | |
| David S. Moore | M | 50 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 7 years |
| Andrew Ajello | M | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 23 years |
| Mikael Dolsten | M | 65 | 15 years | |
| Ronen Tamir | M | 57 | 5 years | |
| Philip F. Fornecker | M | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | - |
| Kalani Scarott | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry McKinnell | M | 81 | 8 years | |
| Ian Read | M | 71 | 41 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| William Steere | M | 88 | 28 years | |
| David Shedlarz | M | 75 | 31 years | |
| George A. Lorch | M | 82 | 15 years | |
| Constance J. Horner | F | 82 | - | |
| Dennis Ausiello | M | 78 | 13 years | |
| Amy Schulman | F | 63 | 6 years | |
| Jonathan Emms | M | - | 20 years | |
| Joseph Arena | M | 69 | 3 years | |
| Martin MacKay | M | 68 | 14 years | |
| Robert Landry | M | 60 | 4 years | |
| Jeffrey A. Frazier | M | 60 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 10 years |
| Paul Fitzhenry | M | 64 | 4 years | |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Anne Phillips | M | 70 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 11 years |
| Alexandra Kropotova | M | 51 | 5 years | |
| Karsten Munk Knudsen | M | 53 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 4 years |
| Yi Ning Zhao | M | 53 | 8 years | |
| Joseph M. Danis | M | - | 10 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Jennifer Schroeder | F | - | 20 years | |
| Ranjeev Krishana | M | 50 | 7 years | |
| Madhukar Bhalla | M | 66 | 3 years | |
| John Mascotte | M | 84 | 4 years | |
| Mace Rothenberg | M | 67 | 13 years | |
| Franklin Raines | M | 74 | 11 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Freda Lewis-Hall | M | 69 | 11 years | |
| Charles H. Hill | M | 69 | 31 years | |
| Frances Fergusson | M | 79 | 9 years | |
| Wyllie Cornwell | M | 76 | 23 years | |
| James Kilts | M | 76 | 13 years | |
| Robert N. Burt | M | 86 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| Michael Brown | M | 83 | 16 years | |
| Peter Corr | M | 76 | 6 years | |
| Stephen W. Sanger | M | 78 | 9 years | |
| Dana George Mead | M | 88 | 12 years | |
| George Milne | M | 80 | 32 years | |
| Alan Levin | M | 62 | 20 years | |
| Lori McNeill | F | 51 | 1 years | |
| Erica L. Mann | F | 66 | 2 years | |
| Stanislav Glezer | M | 51 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Clark
- Personal Network
